SEARCH OHR


WHAT'S NEW?

User Forum
Health-related News
Training Sessions
Most Recent Tracker

FEATURES

Find a Provider
Resources
Free Guides
Tracker Journal
Protocols/Algorithms
Job Postings
 

SOFTWARE SUPPORT

SYSTOC Software
User Forum
Contact Information
Training Sessions
E-mail Questions

ABOUT OHR

Our History
Mission Statement
Business Philosophy
Employment
What Clients Say
Staff Directory
Directions & Map

EXTERNAL LINKS

Ohio Employee Health Partnership
OHROnline Meetings
OHRHelp Meetings
OHR University
Microsoft Live Meeting
Adobe Reader
 

Occupational Health News Summaries  

Infections from Drug-resistant “Superbug” on the Rise

[Posted 10/19/07] A report released this week by the American Medical Association estimated that Methicillin-resistant Staphylococcus aureus (MRSA) was responsible for nearly 19,000 deaths and more than 94,000 life-threatening illnesses in the United States during 2005.

MRSA is the leading cause of skin and soft tissue infections among people in hospitals and, according to the study, the drug-resistant infections are becoming alarmingly more pervasive both in and out of hospitals. The study focused on invasive infections—those that enter the bloodstream or destroy flesh and have the potential to be lethal.

The Centers for Disease Control and Prevention (CDC) used data from nine sites participating in the Active Bacterial Core surveillance (ABCs)/Emerging Infections Program Network from July 2004 through December 2005 to evaluate the scope and magnitude (incidence and distribution) of invasive MRSA infections in the United States. The study investigated and classified 8,987 cases of invasive MRSA. Most cases were healthcare-associated: 58.4% were community-onset infections, 26.6% were hospital-onset infections; 13.7% community-associated infections and 1.3% could not be classified.

The research team, lead by Atlanta-based CDC epidemiologist Dr. R. Monina Klevens, estimated the rate of invasive MRSA in 2005 at 31.8 per 100,000 persons, with higher rates for certain populations.

Klevens indicated that healthcare providers need to do a better job of preventing MRSA. “Invasive MRSA is an important public health problem. This is really a call for action to healthcare settings that we need to do a better job at preventing MRSA,” she said.

Elizabeth A. Bancroft, an epidemiologist at the Los Angeles County Department of Public Health, wrote an editorial that accompanied the article. She noted that “The rate of infection is a lot higher than what was expected,” with more people dying from MRSA infections in the United States in 2005 than died from AIDS.

According to Bancroft, people can protect themselves from MRSA by washing their hands, keeping wounds covered, and maintaining good hygiene. “You don
t always need antibiotics to treat this infection,” she said. “A lot of times, it can be treated by having a doctor drain the pus out.”

Whether they are in the hospital or other healthcare facilities, Bancroft urges patients to make sure that doctors and nurses wash their hands before touching them, starting an IV or inserting a catheter or other invasive device.

She went on to say that in the outside community, MRSA is most often passed from one person to another through casual contact, such as body contact during sports or sharing towels and athletic equipment, particularly in schools and prisons.

Related Links:
JAMA Article
HealthDay Report
CDC Website for Healthcare-related MRSA
NIOSH Website for MRSA and the Workplace

Return to News Summary Page:
Occupational Health News Summaries

 

 

   

Home | Contact Information | E-mail Us | Terms of Use | Privacy Statement